The SOX2 overexpression is commonin many human cancers and is involved in various aspects of metastasisand unfavorably impacts drug resistance, leading to poor survivalrates in cancer patients,54,55 whether these principlesextend to bone cells necessitates further investigation. This evidence concerns the gene SOX2 and cancer.